![Laura Dawson Profile](https://pbs.twimg.com/profile_images/1134324064460218369/GVq6zDY7_x96.jpg)
Laura Dawson
@ldawsonmd
Followers
2K
Following
7K
Statuses
1K
Radiation oncologist. Prof. & Chair Dept. Rad. Oncology. U of Toronto. Princess Margaret Cancer Centre. Liver cancer. ASTRO Past President. Tweets are my own.
Toronto, Ontario
Joined May 2019
Proud to see RTOG1112 RCT published!. Thanks to so many who helped make this possible. #teamwork ‘Hope the next #SBRT #HCC trials are completed much faster. @NRGonc @TedHong9 @Dr_AliHosni @ArndtVogel @aislingbarryro Nice summary of the trial below from @NiuSanford
RTOG 1112 finally out! Sorafenib +/- SBRT in HCC. Congrats to @ldawsonmd & team. Brief summary here & some of my thoughts. Short thread 🧵. 1/
6
30
102
RT @_ShankarSiva: ❓Wondering whats new in stage IV #cancer? Incidence of mets in #breastcancer or #prostatecancer? Role of 🧬genomics, ☢️PET…
0
24
0
RT @DKirschMDPhD: What does excellence in #RadOnc look like? Proud to work with these amazing #WomenWhoCurie
@RadMedPM @pmcancercentre @UHN…
0
8
0
RT @UofTDRO: The #RTi3Conference Webinar is happening next Wednesday!🎟️Don't forget to claim your FREE webinar registration with an Early-B…
0
3
0
RT @NiuSanford: Nice HCC debate & discussion by @lauren_henke! Historically (neo)adjuvant trials in HCC have been designed around resectio…
0
14
0
RT @oncodaily: 🚨New Paper Alert: Hepatocellular Carcinoma – Stereotactic Body Radiotherapy vs Sorafenib Alone in the NRG Oncology/RTOG 1112…
0
5
0
RT @PMResearch_UHN: A practice-changing study on liver cancer🩺 Adding a form of radiotherapy SBRT prior to systemic therapy sorafenib redu…
0
10
0
RT @jryckman3: 1/ Treating hepatocellular carcinoma (HCC) with macrovascular invasion (MVI) has always been challenging. New research compa…
0
20
0
RT @oncodaily: 📌5 Must-read Articles suggested by Vivek Subbiah (@VivekSubbiah) ✍️@aamalayeri @ldawsonmd @Ducreux…
0
2
0
RT @OncoDailyGI: RTOG 1112 is finally out - @NiuSanford
@ldawsonmd
#Cancer #GIOnc #HCC #MedEd #MedX #MedNews #He…
0
1
0
RT @DKirschMDPhD: Congratulations @ldawsonmd and @NRGonc colleagues for this important trial in HCC demonstrating the positive impact of SB…
0
6
0
RT @Mat_Guc: Today is HCC day! - RTOG 1112 - HCC unsuitable for or refractory to local-regional Tx (n=177) - SBRT & Sorafenib vs Sorafenib…
0
35
0
RT @MichaelYanMD: Second, Sun Yat Sen trial. -166 patients with locally recurrent HCC post ablation/resection -SBR…
0
4
0
RT @MichaelYanMD: Great day for HCC, with two very important rad onc trials to improve care for these patients. @RadMedPM @pmcancercentre…
0
7
0
RT @MichaelYanMD: First up: RTOG 1112. -177 patients with BCLC B/C HCC -sorafenib vs. sorafenib + SBRT (note 3/4 h…
0
4
0
RT @ArndtVogel: Liver Transplantation for HCC: An Expanding Cornerstone of Care in the Era of Immunotherapy @JCO_ASCO
0
68
0
RT @ArndtVogel: EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma @JHepatology 🔥Get…
0
111
0
RT @ASTRO_org: ASTRO is pleased to announce the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Grant Award, honoring the career &…
0
29
0